LDX Lumos Diagnostics Holdings Ltd
- 0.052
- -0.001-1.89%
Lumos Diagnostics Holdings Ltd News
Lumos Diagnostics Concludes Initial Phase of Development Deal With Hologic for Fetal Fibronectin Test; Shares Jump 6%
Lumos Diagnostics (ASX:LDX) concluded the initial stage of its development agreement, aimed at creating a novel fetal fibronectin (fFN) test for women's health company Hologic, according to a Monday f
Lumos Diagnostics' FebriDx May Help Optimize Antibiotic Use in Children With Febrile Respiratory Infections, Study Shows
International journal Infectious Diseases and Clinical Microbiology has published results of Lumos Diagnostics Holdings' (ASX:LDX) FebriDx study in 216 pediatric patients, according to a Monday Austra
Lumos Diagnostics Hires Henry Schein as US Distributor for Respiratory Infection Blood Test; Shares Rise 4%
Lumos Diagnostics (ASX:LDX) hired Nasdaq-listed medical supply firm Henry Schein as the US distributor for its FebriDx blood-based respiratory infection diagnostic test. Henry Schein is currently dist
Lumos Diagnostics' Q4 Revenue Jumps 55%
Lumos Diagnostics (ASX:LDX) reported Wednesday that its unaudited revenue for the quarter ended Dec. 31, 2023, was $1.7 million, marking a 55% jump from $1.1 million reported in the preceding quarter.
Australian Shares Rise Ahead of US Inflation Data
Australian shares rose Thursday ahead of the release of key US inflation data to better gauge the direction of future monetary policy. The S&P/ASX 200 Index rose 37.50 points, or 0.5%, to 7,506.00. In
Lumos Diagnostics Signs Development and IP Agreements With Hologic; Shares Up 24%
Point-of-care diagnostic solutions provider Lumos Diagnostics (ASX:LDX) has signed two new agreements with US-based women's health company Hologic for the development of and intellectual property righ
Stocks of the Hour: Norfolk Metals, Aspire Mining, Lumos Diagnostics
Norfolk Metals (ASX:NFL) has announced that phase 2 drilling has commenced at the Orroroo Uranium Project. Executive Chairman Ben Phillips comments: "The maiden drill program has proceeded as schedule
Lumos Diagnostics Raises AU$2.7 Million to Support US Launch of FebriDx, ViraDx; Shares Down 6%
Lumos Diagnostics (ASX:LDX) raised AU$2.7 million via a private placement of 37.9 million shares at AU$0.07 apiece. Proceeds will be used to provide additional working capital to support the launch of
US FDA Grants Emergency Use Authorization for Lumos Diagnostics' ViraDx
The US Food and Drug Administration granted Lumos Diagnostics' (ASX:LDX) ViraDx test an emergency use authorization and a clinical laboratory improvement amendments waiver, the diagnostic technology c
Lumos Diagnostics Secures Europe, Japan Patents for Core Camera Reader
Lumos Diagnostics (ASX:LDX) secured patents in Europe and Japan for its core camera reader. The patents cover the use of the diagnostic technology company's reader technology in the European and Japan
Lumos Diagnostics Expands FebriDx Market to Netherlands
Lumos Diagnostics (ASX:LDX) further expanded the distribution of point-of-care test FebriDx to include the Netherlands. This was done through a distribution agreement with healthcare and medical produ
Lumos Diagnostics Secures R&D Tax Rebate for Fiscal Year 2022
Lumos Diagnostics (ASX:LDX) secured a tax rebate worth AU$705,193 from the Australian government's research and development tax incentive scheme for the fiscal year ended June 30, 2022. The refund is
Lumos Diagnostics Signs Partnership With Henry Schein Medical for FebriDx Distribution; Shares Jump 8%
Lumos Diagnostics (ASX:LDX) signed a distribution agreement with Henry Schein Medical for the FebriDx point-of-care test, the point-of-care diagnostic test technology services provider said Tuesday. T
Stocks of the Hour: ABx Group, Lumos Diagnostics, OD6 Metals
ABx Group (ASX:ABX) announced that their REE Mineral Resource increased by 30% to 27 million tonnes. MD and CEO Mark Cooksey said in response, "Our northernmost discovery hole, located 5km NE of Deep
ASX Rises 0.59% on FY24s First Day, Driven by Seasonal Trade Strategy
Supported by positive sentiment from Wall Street, the S&P/ASX 200 closed 0.59 per cent higher at 7,246.10, with the benchmark index gaining 0.3% and nine out of 11 sectors experiencing gains.Additiona
Stocks of the Hour: Lumos Diagnostics, Kuniko, Asra Minerals, Sunstone Metals
Lumos Diagnostics (ASX:LDX) has received FDA clearance for its FebriDx product, which can rapidly differentiate viral from bacterial infections at point of care. Doug Ward, CEO commented, "With this c
Analysis
Price Target
No Data
